Mitochondrial Syndromes with Leukoencephalopathies

Abstract

White matter involvement has recently been recognized as a common feature in patients with multisystem mitochondrial disorders that may be caused by molecular defects in either the mitochondrial genome or the nuclear genes. It was first realized in classical mitochondrial syndromes associated with mitochondrial DNA (mtDNA) mutations, such as mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), Leigh's disease, and Kearns-Sayre's syndrome. Deficiencies in respiratory chain complexes I, II, IV, and V often cause Leigh's disease; most of them are due to nuclear defects that may lead to severe early-onset leukoencephalopathies. Defects in a group of nuclear genes involved in the maintenance of mtDNA integrity may also affect the white matter; for example, mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) caused by thymidine phosphorylase deficiency, Navajo neurohepatopathy (NNH) due to MPV17 mutations, and Alpers syndrome due to defects in DNA polymerase gamma (POLG). More recently, leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) has been reported to be caused by autosomal recessive mutations in a mitochondrial aspartyl-tRNA synthetase, DARS2 gene. A patient with leukoencephalopathy and neurologic complications in addition to a multisystem involvement warrants a complete evaluation for mitochondrial disorders. A definite diagnosis may be achieved by molecular analysis of candidate genes based on the biochemical, clinical, and imaging results.

Keywords

mitochondrial leukoencephalopathy - mitochondrial disorders - Leigh's disease - POLG - MNGIE - MPV17 - DARS2

• References

• 1 Wallace DC, Lott MT, Brown MD, Kerstann K. Mitochondria and neuro-ophthalmologic diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, , eds. The Metabolic & Molecular Bases of Inherited Disease. Vol II. 8th ed. New York: McGraw-Hill; 2001: 2425-2509
• 2 Koene S, Smeitink J. Mitochondrial medicine: entering the era of treatment. J Intern Med 2009; 265 (2) 193-209
• 3 Pagliarini DJ, Calvo SE, Chang B , et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell 2008; 134 (1) 112-123
• 4 Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 2005; 354: 162-168
• 5 Lebre AS, Rio M, Faivre d'Arcier L , et al. A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet 2011; 48 (1) 16-23
• 6 Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D. White matter involvement in mitochondrial diseases. Mol Genet Metab 2005; 84 (2) 127-136
• 7 Moroni I, Bugiani M, Bizzi A, Castelli G, Lamantea E, Uziel G. Cerebral white matter involvement in children with mitochondrial encephalopathies. Neuropediatrics 2002; 33 (2) 79-85
• 8 Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorders—past, present and future. Biochim Biophys Acta 2004; 1659 (2–3) 115-120
• 9 Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008; 83 (2) 254-260
• 10 Wong LJ. Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev 2010; 16 (2) 154-162
• 11 de Lonlay-Debeney P, von Kleist-Retzow JC, Hertz-Pannier L , et al. Cerebral white matter disease in children may be caused by mitochondrial respiratory chain deficiency. J Pediatr 2000; 136 (2) 209-214
• 12 El-Hattab AW, Li FY, Schmitt E, Zhang S, Craigen WJ, Wong LJ. MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations. Mol Genet Metab 2010; 99 (3) 300-308
• 13 Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283 (5402) 689-692
• 14 Nishino I, Spinazzola A, Papadimitriou A , et al. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 2000; 47 (6) 792-800
• 15 Tang S, Wang J, Lee NC , et al. Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum. J Med Genet 2011; 48 (10) 669-681
• 16 Scheper GC, van der Klok T, van Andel RJ , et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 2007; 39 (4) 534-539
• 17 Uluc K, Baskan O, Yildirim KA , et al. Leukoencephalopathy with brain stem and spinal cord involvement and high lactate: a genetically proven case with distinct MRI findings. J Neurol Sci 2008; 273 (1–2) 118-122
• 18 Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol 1995; 16 (2) 233-239
• 19 Renard D, Bonnaure H, Labauge P. Teaching NeuroImages: diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes. Neurology 2010; 75 (3) e9
• 20 Ito S, Shirai W, Asahina M, Hattori T. Clinical and brain MR imaging features focusing on the brain stem and cerebellum in patients with myoclonic epilepsy with ragged-red fibers due to mitochondrial A8344G mutation. AJNR Am J Neuroradiol 2008; 29 (2) 392-395
• 21 Biancheri R, Rossi D, Cassandrini D, Rossi A, Bruno C, Santorelli FM. Cavitating leukoencephalopathy in a child carrying the mitochondrial A8344G mutation. AJNR Am J Neuroradiol 2010; 31 (9) E78-E79
• 22 Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol 1999; 19 (1) 28-33
• 23 Jansen PH, van der Knaap MS, de Coo IF. Leber's hereditary optic neuropathy with the 11 778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical, MRI and MRS findings. J Neurol Sci 1996; 135 (2) 176-180
• 24 Lev D, Yanoov-Sharav M, Watemberg N, Leshinsky-Silver E, Lerman-Sagie T. White matter abnormalities in Leber's hereditary optic neuropathy due to the 3460 mitochondrial DNA mutation. Eur J Paediatr Neurol 2002; 6 (2) 121-123
• 25 Nikoskelainen EK, Marttila RJ, Huoponen K , et al. Leber's “plus”: neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 1995; 59 (2) 160-164
• 26 Fruhman G, Landsverk ML, Lotze TE , et al. Atypical presentation of Leigh syndrome associated with a Leber hereditary optic neuropathy primary mitochondrial DNA mutation. Mol Genet Metab 2011; 103 (2) 153-160
• 27 Enns GM, Bai RK, Beck AE, Wong LJ. Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load. Mol Genet Metab 2006; 88 (4) 364-371
• 28 Hung PC, Wang HS. A previously undescribed leukodystrophy in Leigh syndrome associated with T9176C mutation of the mitochondrial ATPase 6 gene. Dev Med Child Neurol 2007; 49 (1) 65-67
• 29 Brautbar A, Wang J, Abdenur JE , et al. The mitochondrial 13513G > A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle. Mol Genet Metab 2008; 94 (4) 485-490
• 30 Gropman A, Chen TJ, Perng CL , et al. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet A 2004; 124A (4) 377-382
• 31 Pereira C, Nogueira C, Barbot C , et al. Identification of a new mtDNA mutation (14724G > A) associated with mitochondrial leukoencephalopathy. Biochem Biophys Res Commun 2007; 354 (4) 937-941
• 32 Seigel RS, Seeger JF, Gabrielsen TO, Allen RJ. Computed tomography in oculocraniosomatic disease (Kearns-Sayre syndrome). Radiology 1979; 130 (1) 159-164
• 33 Oldfors A, Fyhr IM, Holme E, Larsson NG, Tulinius M. Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol 1990; 80 (5) 541-546
• 34 Brown GK, Otero LJ, LeGris M, Brown RM. Pyruvate dehydrogenase deficiency. J Med Genet 1994; 31 (11) 875-879
• 35 Dahl HH, Brown GK. Pyruvate dehydrogenase deficiency in a male caused by a point mutation (F205L) in the E1 alpha subunit. Hum Mutat 1994; 3 (2) 152-155
• 36 Willemsen M, Rodenburg RJ, Teszas A, van den Heuvel L, Kosztolanyi G, Morava E. Females with PDHA1 gene mutations: a diagnostic challenge. Mitochondrion 2006; 6 (3) 155-159
• 37 Loeffen JL, Smeitink JA, Trijbels JM , et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 2000; 15 (2) 123-134
• 38 Schuelke M, Smeitink J, Mariman E , et al. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 1999; 21 (3) 260-261
• 39 Loeffen J, Elpeleg O, Smeitink J , et al. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol 2001; 49 (2) 195-201
• 40 Ogilvie I, Kennaway NG, Shoubridge EA. A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J Clin Invest 2005; 115 (10) 2784-2792
• 41 Saada A, Edvardson S, Rapoport M , et al. C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet 2008; 82 (1) 32-38
• 42 Ferreira M, Torraco A, Rizza T , et al. Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1. Neurogenetics 2011; 12 (1) 9-17
• 43 Brockmann K, Bjornstad A, Dechent P , et al. Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency. Ann Neurol 2002; 52 (1) 38-46
• 44 Burgeois M, Goutieres F, Chretien D, Rustin P, Munnich A, Aicardi J. Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev 1992; 14 (6) 404-408
• 45 Ghezzi D, Goffrini P, Uziel G , et al. SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat Genet 2009; 41 (6) 654-656
• 46 Majoie CB, Akkerman EM, Blank C, Barth PG, Poll-The BT, den Heeten GJ. Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report. AJNR Am J Neuroradiol 2002; 23 (5) 813-816
• 47 Seijo-Martínez M, Castro del Río M, Campos Y , et al. Unusual clinical findings and Complex III deficiency in a family with myotonic dystrophy. J Neurol Sci 2003; 208 (1-2) 87-91
• 48 Rahman S, Brown RM, Chong WK, Wilson CJ, Brown GKA. A SURF1 gene mutation presenting as isolated leukodystrophy. Ann Neurol 2001; 49 (6) 797-800
• 49 Timothy J, Geller T. SURF-1 gene mutation associated with leukoencephalopathy in a 2-year-old. J Child Neurol 2009; 24 (10) 1296-1301
• 50 Shaibani A, Shchelochkov OA, Zhang S , et al. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 2009; 66 (8) 1028-1032
• 51 Tang S, Dimberg EL, Milone M, Wong LJ. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations. J Neurol 2011;
• 52 Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol 1990; 5 (4) 273-287
• 53 Kollberg G, Moslemi AR, Darin N , et al. POLG1 mutations associated with progressive encephalopathy in childhood. J Neuropathol Exp Neurol 2006; 65 (8) 758-768
• 54 Brunetti-Pierri N, Selby K, O'Sullivan M , et al. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI. Neuropediatrics 2008; 39 (3) 179-183
• 55 Bao X, Wu Y, Wong LJ , et al. Alpers syndrome with prominent white matter changes. Brain Dev 2008; 30 (4) 295-300
• 56 Wong LJ, Naviaux RK, Brunetti-Pierri N , et al. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 2008; 29 (9) E150-E172
• 57 Milone M, Wang J, Liewluck T, Chen LC, Leavitt JA, Wong LJ. Novel POLG splice site mutation and optic atrophy. Arch Neurol 2011; 68 (6) 806-811
• 58 Holve S, Hu D, Shub M, Tyson RW, Sokol RJ. Liver disease in Navajo neuropathy. J Pediatr 1999; 135 (4) 482-493
• 59 Karadimas CL, Vu TH, Holve SA , et al. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 2006; 79 (3) 544-548
• 60 Wong LJ, Brunetti-Pierri N, Zhang Q , et al. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology 2007; 46 (4) 1218-1227
• 61 Spinazzola A, Viscomi C, Fernandez-Vizarra E , et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006; 38 (5) 570-575
• 62 Navarro-Sastre A, Martín-Hernández E, Campos Y , et al. Lethal hepatopathy and leukodystrophy caused by a novel mutation in MPV17 gene: description of an alternative MPV17 spliced form. Mol Genet Metab 2008; 94 (2) 234-239
• 63 Randolph LM, Jackson HA, Wang J , et al. Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder. Mol Genet Metab 2011; 102 (2) 149-152
• 64 Isohanni P, Linnankivi T, Buzkova J , et al. DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis. J Med Genet 2010; 47 (1) 66-70
• 65 Mierzewska H, van der Knaap MS, Scheper GC, Bekiesinska-Figatowska M, Szczepanik E, Jurkiewicz E. Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation in the first Polish patient. Brain Dev 2011; 33 (9) 713-717
• 66 Tzoulis C, Tran GT, Gjerde IO , et al. Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene. J Neurol 2011;
• 67 Haas RH, Parikh S, Falk MJ , et al. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 2007; 120 (6) 1326-1333
• 68 Haas RH, Parikh S, Falk MJ , et al; Mitochondrial Medicine Society's Committee on Diagnosis. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 2008; 94 (1) 16-37
• 69 Wong LJ, Scaglia F, Graham BH, Craigen WJ. Current molecular diagnostic algorithm for mitochondrial disorders. Mol Genet Metab 2010; 100 (2) 111-117
• 70 Vasta V, Ng SB, Turner EH, Shendure J, Hahn SH. Next generation sequence analysis for mitochondrial disorders. Genome Med 2009; 1 (10) 100